Keyword: Campath multiple sclerosis
News
24.01.2011
- French drugmaker Sanofi-Aventis extended its snubbed $18.5 billion tender offer for U.S. biotech Genzyme for a second time as the companies continue behind-the-scenes talks to...
News
20.01.2011
- French drugmaker Sanofi-Aventis is likely to extend its $18.5 billion tender offer for Genzyme one last time as it seeks to buy the U.S. maker of drugs for rare diseases, sources...
News
12.01.2011
- Genzyme, the subject of an $18.5 billion hostile takeover bid from Sanofi-Aventis SA, posted preliminary Q4 earnings that fell short of Wall Street forecasts and cut its earnings...
News
11.01.2011
- Genzyme acknowledged on Monday that it was discussing a takeover deal with French drugmaker Sanofi-Aventis, but hopes for a quick agreement cooled as both sides noted differences...
News
10.01.2011
- French drugmaker Sanofi-Aventis and Genzyme Corp are discussing options for significantly raising Sanofi's bid for the the U.S. biotech company to about $80 per share, the Wall...
News
07.01.2011
- Could it be time to talk in the long-running saga of Sanofi-Aventis $18.5 billion bid for Genzyme Corp? There is certainly the opportunity. The two chief executives at the center...
